SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-023842
Filing Date
2021-02-16
Accepted
2021-02-16 16:00:55
Documents
2
Group Members
DALIA BLEYERNEXTECH V GP S.A R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216872d3_sc13g.htm SC 13G 88808
2 EXHIBIT 99.1 tm216872d3_ex99-1.htm EX-99.1 7382
  Complete submission text file 0001104659-21-023842.txt   97732
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91714 | Film No.: 21637714
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G